Shore Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, Shore Capital Partners has acquired 4 companies. It has also invested in 1 other.

Shore Capital Partners’ most common sectors for investment arehealthcare services (63%) and medical products (23%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (38%) and growth capital (30%). In total, Shore Capital Partners has invested in 17 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2017 when it acquired Alliqua BioMedical - TheraBond for $4M.

In the last 3 years, Shore Capital Partners has exited 2 companies. The Firm’s most common exit type is trade sale (60%).

Join Mergr to view Shore Capital Partners’ full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity32
    • M&A Buy Activity27
    • M&A Sell Activity5
  • Total Sectors Invested 6
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 8

Shore Capital Partners LLC

1 E. Wacker Drive, Suite 400,
Chicago, Illinois 60601
United States
(312) 348-7580
www.shorecp.com
info@shorecp.com

Shore Capital Partners is a specialist private equity group focused on healthcare opportunities. Specific areas of interest include infusion therapy, laboratory services, laboratory products/distribution, outpatient rehab therapy, and behavioral health. Shore looks to invest in proven businesses with stable cash-flows and 'significant' growth potential. Prospective companies typically have $5 to $50 million in sales and $1 to $7 million of EBITDA. Shore Capital was formed in 2009 and is based in Chicago.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Consolidation, Divestiture, Growth Capital, Recapitalization, Stake Purchase

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue 5 50
Target EBITDA 1 7
Investment Size - -
Enterprise Value - -
values in millions of USD

M&A Summary

Buy vs Sell

Year ≤ '16 '17 '18 '19 '20 '21 T
Buy (1.6/yr) # 19 3 2 2 - 1 27
vol $4M $4M
Sell (0.4/yr) # 3 - 1 - 1 - 5
  32

Most Recent M&A

Company Date Value Type
Innovative Packaging Co. 2021-03-29 - Buyout (LBO, MBO, MBI)
Vancouver, Washington · www.innovativepackagingco.com
Florida Autism Center 2020-03-05 - Add-on Acquisition
Sanford, Florida · www.floridaautismcenter.info
Main Street Gourmet 2019-09-19 - Secondary Buyout
Cuyahoga Falls, Ohio · www.mainstreetgourmet.com
SCP ENT and Allergy Services LLC (SENTA) 2019-05-17 - Consolidation
Sandy Springs, Georgia · www.sentapartners.com
Hulin Health LLC 2018-04-18 - Growth Capital
Lafayette, Louisiana · www.hulinhealth.com
Network Medical Products Ltd. 2018-03-01 - Buyout (LBO, MBO, MBI)
Ripon, United Kingdom · www.networkmedical.co.uk
The Stepping Stones Group 2018-01-04 - Secondary Buyout
Lafayette, Colorado · www.thesteppingstonesgroup.com
Alliqua BioMedical, Inc. - TheraBond 2017-09-05 4M USD Divestiture
Yardley, Pennsylvania
EyeSouth Partners LLC 2017-03-14 - Buyout (LBO, MBO, MBI)
Atlanta, Georgia · www.eyesouthpartners.com
Argentum Medical LLC 2017-01-25 - Growth Capital
Geneva, Illinois · www.silverlon.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
IZI Medical Products, Inc. 2016-05-03 RadioMed Corp. 2019-12-17 4
Owings Mills, Maryland · www.izimed.com Bartlett, Tennessee
IZI Medical Products, Inc. 2016-05-03 Cook Medical, Inc. - Quick-Core Biopsy & Breast Localization Needle Assets 2019-01-08 3
Owings Mills, Maryland · www.izimed.com Bloomington, Indiana
IZI Medical Products, Inc. 2016-05-03 Benvenue Medical, Inc. - Vertebral Augmentation Systems 2018-09-13 2
Owings Mills, Maryland · www.izimed.com Santa Clara, California
IZI Medical Products, Inc. 2016-05-03 Cook Medical, Inc. - Vertebroplasty Products 2017-05-10 1
Owings Mills, Maryland · www.izimed.com Bloomington, Indiana

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 10 (50%) - 17 (63%) -
Medical Products 6 (30%) - 6 (22%) -
Life Science 1 (5%) 4M (100%) 1 (4%) 4M (100%)
Business Services 1 (5%) - 1 (4%) -
Food 1 (5%) - 1 (4%) -
Packaging 1 (5%) - 1 (4%) -
Total 20 $4M 27 $4M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 19 (95%) 4M (100%) 26 (96%) 4M (100%)
  Illinois 4 (20%) - 4 (15%) -
  Colorado 2 (10%) - 3 (11%) -
  Minnesota 2 (10%) - 2 (7%) -
  Georgia 2 (10%) - 2 (7%) -
  Alabama 2 (10%) - 2 (7%) -
  Michigan - - 2 (7%) -
  Pennsylvania 1 (5%) 4M (100%) 1 (4%) 4M (100%)
  Washington 1 (5%) - 1 (4%) -
  Oregon 1 (5%) - 1 (4%) -
  Ohio 1 (5%) - 1 (4%) -
  Maryland 1 (5%) - 1 (4%) -
  Louisiana 1 (5%) - 1 (4%) -
  California 1 (5%) - 1 (4%) -
  Tennessee - - 1 (4%) -
  New York - - 1 (4%) -
  Florida - - 1 (4%) -
  Arizona - - 1 (4%) -
United Kingdom 1 (5%) - 1 (4%) -
Domestic 19 (95%) 4M (100%) 26 (96%) 4M (100%)
Cross-border 1 (5%) - 1 (4%) -
Total 20 $4M 27 $4M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 4 (20%) - 10 (37%) -
Growth Capital 7 (35%) - 8 (30%) -
Recapitalization 3 (15%) - 3 (11%) -
Divestiture 2 (10%) 4M (100%) 2 (7%) 4M (100%)
Acquisition Financing 2 (10%) - 2 (7%) -
Consolidation 1 (5%) - 1 (4%) -
Secondary Buyout 1 (5%) - 1 (4%) -
Total 20 $4M 27 $4M

Exits by Deal Type

Type Total # Value
Secondary Sale 2 (40%) -
Trade Sale 2 (40%) -
Trade Sale - Public Company 1 (20%) -
Total 5 -

Deal Values

buy # Total
< $100M 1 $4M
TOTAL $4M
Largest Alliqua BioMedical, Inc. - TheraBond
$4M (2017-09-05)

M&A Connections

Deals
Acquired from
Investor(s)
4%
1 (4%)
Strategic(s)
7%
2 (7%)
Exited to
Investor(s)
40%
2 (40%)
Strategic(s)
60%
3 (60%)

 Subscribe to unlock this and 169,048
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.2K Private Equity Firms
  • 158K M&A Transactions
  • 165K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.3K M&A Advisors
    (Investment Banks and Law Firms)
  • 57K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.